Navigation Links
Researchers devise means to create blood by identifying earliest stem cells
Date:8/29/2008

lasts, but turning off the enzyme also helps guide the cells' replication and maturation into either blood or endothelial cells. By treating the hemangioblasts with losartan, an ACE pathway blocking agent routinely used to treat high blood pressure, dramatically increased the rate of blood cell production.

The next step, Zambidis adds, is to test this research in animal models and show that "we can make lots and lots of blood cells from human stem cells for transfusions, regenerate new vascular trees for heart diseases, as well as create test tube factories for making transplantable blood cells that treat diseases. We are very far from treatment," Zambidis cautions, "but this is a big step."

If the new technique of mass producing progenitor blood cells is eventually proven to work in humans, it would allow patients getting bone marrow transplants to have their own stem cells creating the blood they need, significantly reducing rejection risk.


'/>"/>

Contact: Valerie Mehl
mehlva@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers discover atomic bomb effect results in adult-onset thyroid cancer
2. Antidepressants need new nerve cells to be effective, UT Southwestern researchers find
3. Indiana U researchers launch social networking and research management tool for scientists
4. UC Davis researchers define characteristics, treatment options for XXYY syndrome
5. Munich researchers discover key allergy gene
6. Rapid test for pathogens developed by K-State researchers
7. OU researchers isolate microorganisms that convert hydrocarbons to natural gas
8. UH researchers win top prize for research with humanitarian applications
9. Caltech researchers awarded $10M for molecular programming project
10. Researchers study facial structures, brain abnormalities to reveal formula for detection of autism
11. Mount Sinai researchers discover technology that silences genes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...UMBUS, Ohio Ohio State University cancer research...oth kills brain-tumor cells and blocks the growth ...ws that viruses designed to kill cancer cells onc...gressive brain tumors if they also carry a gene fo...The protein, called vasculostatin, is normally pro...
(Date:12/1/2009)... , NEW YORK, Dec. 1 iQor, a ...PO) services, was included in the 2009 InfoWorld ...metric-enabled ERP system, TeQ21. This was the fir...e recognized among this prestigious list of compan.... "TeQ21 is completely transforming the way we do ...
(Date:12/1/2009)...eliness, like a bad cold, can spread among groups ...the University of California-San Diego and Harvard...ale study that has been following health condition... that lonely people tend to share their loneliness...ly, disconnected people moves to the fringes of so...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Loneliness can be contagious 2Loneliness can be contagious 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 1TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 2TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 4More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 1More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 2More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 3More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 4
...he projects will together provide to the GBIF netw...8 million species-occurrence data records as well ...rencing service and a workflow for extracting info...vailable in a database format). , As directed in t... address major global issues, including Global Cli...
...il 2008 - FEBS Letters, one of the leading journal...unced today an exciting new enhancement to the jou... , A Structured Digital Abstract in FEBS Letters ...tract comprising of a series of sentences each of ...al entities, mentioning the method used to study t...
... Care Congress is the premier forum for health car...s and to network with key leaders. The 2008 Congre...fficials from the nation,s largest employers, hosp...l and biotech companies, and government. , One of...alth Care Agenda, will feature key health care adv...
Other Biology News:GBIF seed money awards for 2007-2008 2FEBS Letters Structured Digital Abstracts experiment 25th Annual World Health Care Congress April 21-23, Washington, D.C. 2
(Date:12/2/2009)... JERUSALEM, Israel, December 2 ...aluating the preclinical (animal study) safety and... technology from Weill,Cornell Medical College and...eat inherited anemias such as Cooley,s Anemia. ,...nologies to expand, ex vivo,populations of stem/p...
(Date:12/2/2009)...RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ --...any") (OTC Bulletin Board: EMDY), a leading,produc...a, milk powder and,soybean products in China, toda...he Spring issue of US Food & Drink Executive, ...,000 executives in the food and beverage industry....
(Date:12/2/2009)...CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zent..."), a global biopharmaceutical company focused on ...at the U.S. Food and Drug Administration (FDA) has...PI3K/Akt pathway inhibitor compound, perifosine (K... multiple myeloma. Keryx Biopharmaceuticals, Inc. ...
(Date:12/2/2009)... The Scientist, a leading scientific magazin...rsquo; Evolve “Intelligent” EMCCD came... 10 Innovations of 2009. , ...EMCCD camera from Photometrics ®, a designer...D cameras for the life sciences, was ranked fourth...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...1 Cardium Therapeutics (Amex:,CXM) announced that...ct,offering with institutional and other accredite...nced on January 31, 2008. Empire Asset Management,...transaction., (Logo: http://www.newscom.com/cgi-...ere offered pursuant to an effective shelf registr...
...Feb. 1 Amicus Therapeutics,Inc. (Nasdaq: FOLD ),...nd,Chief Executive Officer, will present a corpora...al, Biotechnology & Medical Device Conference in,N... am (Eastern Standard,Time) at the Grand Hyatt Hot...y be accessed by visiting,Amicus, website at http...
...IFF LAKE, N.J., Feb. 1 Eisai Co., Ltd.,(Headquart...i,s U.S.,subsidiary, Eisai Corporation of North Am... Chairman & CEO: Hajime Shimizu), today announced .... Food and Drug,Administration (FDA) of a New Drug...in mesylate) for third-line treatment of advanced ...
Other Biology Technology:Cardium Completes $5.3 Million Registered Direct Offering 2Cardium Completes $5.3 Million Registered Direct Offering 3Cardium Completes $5.3 Million Registered Direct Offering 4Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application 2Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application 3
Cyno Serum from Innovative Research
Normal Porcine Serum from Equitech-Bio
Porcine Serum from Irvine Scientific
Anti-Foam Reagent from Promega
Biology Products: